Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 25;3(3):e194. doi: 10.1002/ski2.194

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

(a) Depression prevalence in each hair loss disease shows relatively similar incidence to the control, however this is higher than WHO estimate, which puts depression at 4.5% in healthy individuals. There were no publications associating TE with depression. (b) Anxiety prevalence distribution in hair loss patients and in the general population shows higher levels of anxiety in all hair loss types relative to levels in the general population. (c) The correlation between acute stress and hair loss was only reported in AA and other alopecia patients, not in AGA or cases of TE. (d) The association of several other psychiatric disorders with each hair loss disease suggests highest prevalence in AGA and TE, however in each case this is a single datapoint from one publication. AA, alopecia areata; AGA, androgenetic alopecia; TE, telogen effluvium.